The Food and Drug Administration (FDA) has approved a domestically-developed and produced antibody reagent for the COVID-19 coronavirus disease, the first of its kind licensed in Taiwan, an FDA official said Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Taiwan's Teng shines despite Giants' 8-1 loss to D-Backs
09/16/2025 03:13 PM - Society
Imported melons, cakes blocked at border over pesticide, preservatives
09/16/2025 03:10 PM - Society
President Lai witnesses installation of Danjiang Bridge's final span
09/16/2025 02:55 PM - Politics
Taiwan raises travel alert to Nepal following deadly unrest
09/16/2025 02:23 PM - Business
Taiwan shares close up 1.07%
09/16/2025 01:51 PM